老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunovant, Inc.

16.29
-0.4800-2.86%
盘后：16.290.00000.00%16:20 EDT
成交量：105.78万
成交额：1,727.54万
市值：27.84亿
市盈率：-5.97
高：17.15
开：17.08
低：15.95
收：16.77
数据加载中...
总览公司新闻公告
2020/09/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/18

重要事件披露

8-K - Current report
2020/09/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/31

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/25

重要事件披露

8-K - Current report
2020/08/21

重要事件披露

8-K - Current report
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/06/29

重要事件披露

8-K - Current report
2020/06/15

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/14

重要事件披露

8-K - Current report
2020/04/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/10

招股说明书

General form for registration of securities under the Securities Act of 1933
更多